Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.15998 http://scihub22266oqcxt.onion/10.1111/ajt.15998 32400084!7272871!32400084     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Transplant 2020 ; 20 (10): 2928-2932 Nephropedia Template TP {{tp|p=32400084|t=2020. SARS-CoV-2 infection in two patients following recent lung transplantation |pdf=|usr=}}{{32400084}} gab.com Text SARS-CoV-2 infection in two patients following recent lung transplantation JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32400084 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has become a global health problem with pandemic character. Lung transplant recipients may be particularly at risk due to the high degree of immunosuppression and the lung being the organ primarily affected by COVID-19. We describe a 16-year-old male and a 64-year-old female recently lung transplanted patients with COVID-19 during inpatient rehabilitation. Both patients were receiving triple immunosuppressive therapy and had no signs of allograft dysfunction. Both patients had close contact with a person who developed COVID-19 and were tested positive for SARS-CoV-2. Subsequently, both patients underwent systematic screening and SARS-CoV-2 was ultimately detected. Although the 16-year-old boy was completely asymptomatic, the 64-year-old woman developed only mild COVID-19. Immunosuppressive therapy was unchanged and no experimental treatment was initiated. No signs of graft involvement or dysfunction were noticed. In conclusion, our report of patients with asymptomatic SARS-CoV-2 infection and mild COVID-19, respectively, may indicate that lung transplant recipients are not per se at risk for severe COVID-19. Further observations and controlled trials are urgently needed to study SARS-CoV-2 infection in lung transplant recipients. Twit Text FOAVip SARS-CoV-2 infection in two patients following recent lung transplantation ????Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32400084 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32400084 #FOAvip English Wikipedia <ref>{{Cite pmid|32400084}}</ref> SARS-CoV-2 infection in two patients following recent lung transplantation #MMPMID32400084 Koczulla RA; Sczepanski B; Koteczki A; Kuhnert S; Hecker M; Askevold I; Schneider C; Michel S; Kneidinger N Am J Transplant 2020[Oct]; 20 (10): 2928-2932 PMID32400084show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has become a global health problem with pandemic character. Lung transplant recipients may be particularly at risk due to the high degree of immunosuppression and the lung being the organ primarily affected by COVID-19. We describe a 16-year-old male and a 64-year-old female recently lung transplanted patients with COVID-19 during inpatient rehabilitation. Both patients were receiving triple immunosuppressive therapy and had no signs of allograft dysfunction. Both patients had close contact with a person who developed COVID-19 and were tested positive for SARS-CoV-2. Subsequently, both patients underwent systematic screening and SARS-CoV-2 was ultimately detected. Although the 16-year-old boy was completely asymptomatic, the 64-year-old woman developed only mild COVID-19. Immunosuppressive therapy was unchanged and no experimental treatment was initiated. No signs of graft involvement or dysfunction were noticed. In conclusion, our report of patients with asymptomatic SARS-CoV-2 infection and mild COVID-19, respectively, may indicate that lung transplant recipients are not per se at risk for severe COVID-19. Further observations and controlled trials are urgently needed to study SARS-CoV-2 infection in lung transplant recipients. |*Lung Transplantation[MESH] |*Transplant Recipients[MESH] |Adolescent[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*genetics[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis/drug therapy/transmission[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis/drug therapy/transmission[MESH] |Postoperative Period[MESH] |RNA, Viral/analysis[MESH] |SARS-CoV-2[MESH]SARS-CoV-2 infection in two patients following recent lung transplanta(epmc).pdf DeepDyve Pubget Overpricing